Marketing Manager IMARC Group© 2022 IMARC All Rights Reserved
Author: Elena Anderson
Copyright © IMARC Service Pvt Ltd. All Rights Reserved Global Pet Cancer Therapeutics Market Research Report 2022-2027
Report DescriptionAbout IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description Report Description and Highlights
Pet Cancer Therapeutics Market Outlook 2022-2027: According to the latest report by IMARC Group, titled “Pet Cancer Therapeutics Market: Global Industry, Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global pet cancer therapeutics market reached a value of US$ 245.2 Million in 2021. Pet cancer therapeutics refer to treatment alternatives that have the capability to lessen the effect of cancerous cell tumor growth in domesticated animals. They aid in the treatment of mast cell cancer, lymphoma, melanoma and mammary and squamous cell cancer in cats, dogs and other pet Petanimals.cancer therapeutics mainly include immunotherapy vaccines, targeted therapies, chemotherapy drugs and combination therapies that are employed depending on the type, nature, and stage of the cancer. They gradually neutralize or shrink the cancer cells using various bacteria and plant-based drugs that prevent the tumor from spreading and affecting other parts of the body. They also help relieve other symptoms such as pain and shortness of breath. Request for a PDF sample of this report: https://www.imarcgroup.com/pet-cancer-therapeuticsmarket/requestsample
The increasing prevalence of cancer in animals is creating a positive outlook for the market. Cancer is primarily observed in aging animals, with certain breeds possessing higher susceptibility than others. In line with this, the increasing domestication of animals and rising awareness among pet owners regarding pet health is favoring the market growth. Apart from this, rapid advancements in diagnostic procedures and the integration of robotics and artificial intelligence (AI) to reduce the need for surgeries and help veterinarians make informed decisions and treatment plans are providing an impetus to the market growth. Additionally, the launch of highly targeted and specific therapies for treating cancer with minimal side effects is positively impacting the market growth. Other factors, including extensive research and development (R&D) activities to engineer novel formulations and therapies, the rising expenditure capacities of consumers, and an increasing number of veterinary oncologists, are anticipated to drive the market toward growth. On account of the aforementioned factors, the market is expected to reach US$ 435.2 Million by 2027, exhibiting a CAGR of 10.1% during 2022-2027. View Report TOC, Figures and Tables: https://www.imarcgroup.com/pet-cancer-therapeutics-market
Global Pet Cancer Therapeutics Market Drivers/Constraints:
Report Description Report Description and Highlights
Report Description Report Description and Highlights Key Market Segmentation The research report includes the following segments: Breakup by Therapy: • Chemotherapy • Radiation Therapy • Immunotherapy • Combination Therapy • Others Breakup by Animal Species: • Cats • Dogs • Others
Report Description Report Description and Highlights Breakup by Cancer Type: • Lymphoma • Mast Cell Cancer • Melanoma • Mammary and Squamous Cell Cancer • Others
Report Description Report Description and Highlights Breakup by End-User: • Veterinary Hospitals and Clinical Pharmacies • Retail Pharmacies • Online Pharmacies • Others Breakup by Region: • Europe • North America • Asia Pacific • Middle East and Africa • Latin America Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. click here: https://www.imarcgroup.com/request?type=report&id=4472&flag=C
Report Description Report Description and Highlights Competitive Landscape: • AB Science • Boehringer Ingelheim International GmbH • Elanco Animal Health Incorporated • ELIAS Animal Health LLC • Karyopharm Therapeutics, Pfizer Inc. • Regeneus Ltd. • Rhizen Pharmaceuticals AG • Torigen Pharmaceuticals Inc. • VetDC Inc. • Virbac • Zoetis Inc.
Report Description Key Questions Answered in the Report 1. How has the global pet cancer therapeutics market performed so far and how will it perform in the coming years? 2. What has been the impact of COVID-19 on the global pet cancer therapeutics market? 3. What are the key regional markets? 4. What is the breakup of the market based on the therapy? 5. What is the breakup of the market based on the animal species? 6. What is the breakup of the market based on the cancer type? 7. What is the breakup of the market based on the end user? 8. What are the various stages in the value chain of the industry? 9. What are the key driving factors and challenges in the industry? 10. What is the structure of the global pet cancer therapeutics market and who are the key players? 11. What is the degree of competition in the industry?
Report Description Table of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources. 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends
Report Description Table of Contents 5 Global Pet Cancer Therapeutics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Therapy 6.1 Chemotherapy 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Radiation Therapy 6.2.1 Market Trends 6.2.2 Market Forecast Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/pet-cancer-therapeutics-market/toc
A partial List of our Clients We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients
A partial List of our Clients We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing.
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Report Description Report Description and Highlights
FOR MORE DETAILS Visit us at : Stay With Us: TELEPHONE: +1-631-791-1145 -MAIL: sales@imarcgroup.com https://www.imarcgroup.com Contact Us
